U
Ulrich Bogdahn
Researcher at University of Regensburg
Publications - 347
Citations - 36060
Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.
Papers
More filters
Journal ArticleDOI
Introspection: a curious case of lens luxation.
Roland Backhaus,Gerhard Schuierer,Christoph Röhrer,M. Andreea Gamulescu,Horst Helbig,Ulrich Bogdahn,Felix Schlachetzki +6 more
TL;DR: History revealed sudden loss of vision in the right eye to movement perception after surgery for abdominal aortic aneurysm 6 months ago, andLens luxation is a common complication in Marfan's syndrome.
Journal ArticleDOI
Dynamic and three-dimensional transcranial sonography studies of an asymptomatic, cerebral convexity arachnoid cyst: Case report
Felix Schlachetzki,Thilo Hölscher,Odo-Winfried Ullrich,M.D. Sabine Kübber,Wendelin Blersch,Birgit Götz,Katrin Ocklenburg,Berthold Schalke,Ulrich Bogdahn +8 more
TL;DR: A 16-year-old female patient who presented with a space-occupying, cerebral convexity arachnoid cyst and recurrent tension-type headache underwent examination for raised intracranial pressure (ICP) by using a standard color-coded duplex sonography system attached to a personal computer–based system for 3D data acquisition.
Patent
Proteine d'inhibition de melanomes
TL;DR: The authors concerne a proteine dinhibition de melanomes, des sequences d'acides nucleiques de codage de ladite proteine, un procede de preparation de cette proteine and son utilisation for preparer un agent therapeutique.
Journal ArticleDOI
"Fußkribbeln", Vergesslichkeit und progrediente Wesensveränderung bei einer 63-jährigen Patientin.
Thomas Karrasch,M. Weil,R. Voltz,C. Schulz,F. Audebert,M. Woenckhaus,Ferdinand Hofstädter,Ulrich Bogdahn,Jürgen Schölmerich,A. Schäffler,A. Steinbrecher +10 more
TL;DR: In this paper, a 63-year-old female was admitted to the hospital with leg and forearm paresthesias and found progressive ataxia, dementia, and psychosocial deterioration.
Journal ArticleDOI
Response to MC Chamberlain: Convection-enhanced delivery of transforming growth factor-β2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to W Wick and M Weller: Trabedersen to target transforming growth factor-β: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142)
TL;DR: The trabedersen study in high grade glioma was designed as a randomized and active-controlled phase IIb study with high-quality standards, including central histopathology and central MRI reading as discussed by the authors.